CPHI vs LYFT · rev $4.5M vs P/E 108, rev $5.79B
China Pharma Holdings Inc (CPHI) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
CPHI currently screens at market cap $29.0M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the CPHI and LYFT stock pages for the full models.
Not investment advice.